US Stem Cell Inc (USRM)

[Zues]

I think there is more pain in store before the bounce (hope I'm wrong). Q2 will help. Looking at the big picture now. I expect Tomas will state they are renewing their effort to go after RMAT now that the guidelines will be released Sept. If Texas really is in play then the increased revenues from that clinic, along with the others, will help to offset some costs associated with RMAT and eventual FDA approval.